The University of Chicago Header Logo

Connection

Robert Wollmann to Mice, Transgenic

This is a "connection" page, showing publications Robert Wollmann has written about Mice, Transgenic.
Connection Strength

0.209
  1. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci. 1997 Jun 01; 17(11):4170-9.
    View in: PubMed
    Score: 0.028
  2. The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells. J Virol. 2011 Sep; 85(18):9377-84.
    View in: PubMed
    Score: 0.018
  3. Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy. J Neuroimmunol. 2009 Sep 29; 214(1-2):93-100.
    View in: PubMed
    Score: 0.016
  4. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J Neurosci. 2008 Nov 05; 28(45):11537-49.
    View in: PubMed
    Score: 0.015
  5. A subgenomic segment of Theiler's murine encephalomyelitis virus RNA causes demyelination. J Virol. 2008 Jun; 82(12):5879-86.
    View in: PubMed
    Score: 0.015
  6. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. J Neurosci. 2007 Dec 26; 27(52):14515-24.
    View in: PubMed
    Score: 0.014
  7. Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. J Clin Invest. 2007 Oct; 117(10):2903-12.
    View in: PubMed
    Score: 0.014
  8. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation. J Virol. 2007 Mar; 81(6):2831-7.
    View in: PubMed
    Score: 0.013
  9. Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model. Neurobiol Dis. 2006 Aug; 23(2):462-70.
    View in: PubMed
    Score: 0.013
  10. The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J Biol Chem. 2006 May 12; 281(19):13559-13565.
    View in: PubMed
    Score: 0.013
  11. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science. 2002 Nov 29; 298(5599):1781-5.
    View in: PubMed
    Score: 0.010
  12. Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. J Neurosci. 2002 Aug 01; 22(15):6447-57.
    View in: PubMed
    Score: 0.010
  13. Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly. J Biol Chem. 2001 Jun 15; 276(24):21785-90.
    View in: PubMed
    Score: 0.009
  14. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci. 1998 May 13; 841:167-80.
    View in: PubMed
    Score: 0.007
  15. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse. 1997 Dec; 27(4):367-77.
    View in: PubMed
    Score: 0.007
  16. A transgenic mouse model of the slow-channel syndrome. Muscle Nerve. 1996 Jan; 19(1):79-87.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.